6 天之前 · Why IRTR? 1. Easy access: One ETF to access a diverse portfolio of stock and bond ETFs designed for investors expecting to retire or begin withdrawing assets in the near future. 2. Low cost: Low fees combined with the tax efficiency of an ETF can help keep more money invested and working to support retirement spending needs. 3.

2024年12月30日 · The industry-leading iShares LifePath Target Date ETF series spearheads a new opportunity for retirement investors. Launched in late 2023, this series is the only target-date strategy offered in an...

2024年6月24日 · Learn everything you need to know about iShares LifePath Retirement ETF (IRTR) and how it ranks compared to other funds. Research performance, expense ratio, holdings, and volatility to see if...

Find the latest Ishares Lifepath Retirement ETF (IRTR) stock quote, history, news and other vital information to help you with your stock trading and investing.

IRTR | NYSE Arca Annual Shareholder Report — July 31, 2024. This annual shareholder report. contains important information about iShares. LifePath Retirement ETF (the “Fund”) for the period of October 17, 2023 to July 31, 2024. You can find additional information about the Fund at blackrock.com/fundreports.

本基金是一組被稱為“LifePath ETF”的基金之一，每一隻基金都試圖根據定量衡量的風險提供退休結果，投資者在特定的時間範圍內平均可能願意接受這些風險。 在正常情況下，本基金將至少80%的資產投資於證券或其他金融工具，這些證券或其他金融工具是其自訂模型基準（退休自訂基準）中包含的證券的組成部分或具有類似經濟特徵。 績效計算為原幣別報酬，且皆有考慮配息情況 …

鉅亨美股頻道提供你最完整的IRTR - iShares LifePath Retirement ETF 、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲利、重要事件及股利配發。

Get the latest iShares LifePath Retirement ETF (IRTR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...

2024年8月5日 · A high-level overview of Ishares Lifepath Retirement ETF (IRTR). Stay up to date on the latest price, chart, news, analysis, fundamentals, trading and investment tools.

2024年2月22日 · 在这项开放标签多中心试验中，2012年6月至2017年11月期间，261名肌肉浸润性或淋巴结阳性非转移性上尿路上皮癌症患者被随机分配接受吉西他滨与顺铂或卡铂的辅助治疗（n=132），或在根治性肾输尿管切除术后接受监测（n=129）。 试验的初步分析表明，在这一患者群体中使用化疗与提高无病生存率有关。 总生存率是次要终点；在进行初步分析时，数据还不成熟。 截至2022年2月，中位随访时间为65个月，化疗组的50名患者和监测组的67名患者为无 …